021-51111890
购物车（）
sales@molnova.cn
L-4FPG
CAS No. 19883-57-9
L-4FPG ( 4-Fluoro-L-Phenylglycine | 4-Fluorophenylglycine )
产品货号. M27369 CAS No. 19883-57-9
L-4FPG 抑制中性氨基酸转运蛋白 ASCT1 和 ASCT2。它还显示出良好的大脑渗透性，并有效减少安非他明引起的过度运动。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 1G | ￥340 | 有现货 |
|
生物学信息
-
产品名称L-4FPG
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述L-4FPG 抑制中性氨基酸转运蛋白 ASCT1 和 ASCT2。它还显示出良好的大脑渗透性，并有效减少安非他明引起的过度运动。
-
产品描述L-4FPG inhibits the neutral amino acid transporters ASCT1 and ASCT2. It also shows good brain penetration and potently reduces amphetamine-induced hyperlocomotion.
-
体外实验Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
体内实验——
-
同义词4-Fluoro-L-Phenylglycine | 4-Fluorophenylglycine
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number19883-57-9
-
分子量169.155
-
分子式C8H8FNO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 1.96 mg/mL (11.59 mM)
-
SMILESN[C@H](C(O)=O)c1ccc(F)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Loquais Y, Gloaguen E, Alauddin M, Brenner V, Tardivel B, Mons M. On the near UV photophysics of a phenylalanine residue: conformation-dependent ππ* state deactivation revealed by laser spectroscopy of isolated neutral dipeptides. Phys Chem Chem Phys. 2014 Oct 28;16(40):22192-200. doi: 10.1039/c4cp03401e. Epub 2014 Sep 12. PubMed PMID: 25213197.
产品手册
关联产品
-
Oleonuezhenide
Oleonuezhenide 是中药女贞子中的天然产物，具有神经保护作用，也被认为可以治疗骨质疏松症。
-
Mezagitamab
Mezagitamab (TAK-079) 是一种 IgG1λ 抗 CD38 的单克隆抗体。Mezagitamab 通过抗体和补体依赖性细胞毒性耗尽表达 CD38 的肿瘤细胞。Mezagitamab 在复发/难治性多发性骨髓瘤 (RRMM) 和原发性血小板减少性紫癜 (ITP) 中有潜在应用。
-
Kobusin
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential.
